Detalhe da pesquisa
1.
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.
Mol Cancer
; 22(1): 93, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291608
2.
Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis.
J Transl Med
; 21(1): 244, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020242
3.
Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.
Mol Cancer
; 22(1): 101, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370104
4.
Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network Meta-Analysis.
J Natl Cancer Inst
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38885371
5.
MRI radiomics for brain metastasis sub-pathology classification from non-small cell lung cancer: a machine learning, multicenter study.
Phys Eng Sci Med
; 46(3): 1309-1320, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460894
6.
A multiomics approach-based prediction of radiation pneumonia in lung cancer patients: impact on survival outcome.
J Cancer Res Clin Oncol
; 149(11): 8923-8934, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154927
7.
Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial.
iScience
; 26(9): 107634, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664612
8.
The value of postoperative radiotherapy in thymoma patients with myasthenia gravis.
Radiother Oncol
; 183: 109644, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990391
9.
The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
Front Immunol
; 13: 875488, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35693805